Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona James

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2017
Generalized myoclonic epilepsy with photosensitivity in juvenile dogs caused by a defective DIRAS family GTPase 1Franziska Wielaender, Riika Sarviaho, Fiona James, et al.
The Lancet Regional Health. Western Pacific|November 18, 2024
Impact of time to antibiotics on clinical outcome in paediatric febrile neutropenia: a target trial emulation of 1685 episodesGabrielle M Haeusler, S Ghazaleh Dashti, Fiona James, et al.
The Lancet Regional Health. Western Pacific|May 3, 2021
Multi-site assessment of rapid, point-of-care antigen testing for the diagnosis of SARS-CoV-2 infection in a low-prevalence setting: A validation and implementation studyStephen Muhi, Nick Tayler, Tuyet Hoang, et al.
JAMA Internal Medicine|July 17, 2023
Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy: The PALACE Randomized Clinical TrialAna Maria Copaescu, Sara Vogrin, Fiona James, et al.
Open Forum Infectious Diseases|September 13, 2021
Defective Severe Acute Respiratory Syndrome Coronavirus 2 Immune Responses in an Immunocompromised Individual With Prolonged Viral ReplicationClaire L Gordon, Olivia C Smibert, Natasha E Holmes, et al.
BMJ Open|August 17, 2022
Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)Fiona James, Michelle S Y Goh, Effie Mouhtouris, et al.
Research Square|August 31, 2021
Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severityWuji Zhang, Brendon Chua, Kevin Selva, et al.
Nature Communications|November 24, 2025
High expression of interleukin-18 receptor alpha correlates with severe respiratory viral disease and defines T cells with reduced cytotoxic signaturesAira F Cabug, Jeremy Chase Crawford, Hayley A McQuilten, et al.
Immunity|May 5, 2021
CD8<sup>+</sup> T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuityThi H O Nguyen, Louise C Rowntree, Jan Petersen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2026
Direct Oral Challenge for Penicillin Allergy: A Hospital Implementation Evaluation Via the International Network of Antibiotic Allergy Nations (iNAAN) StudyElise A Mitri, Sara Vogrin, Camille Paynter, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2017
Generalized myoclonic epilepsy with photosensitivity in juvenile dogs caused by a defective DIRAS family GTPase 1Franziska Wielaender, Riika Sarviaho, Fiona James, et al.
The Lancet Regional Health. Western Pacific|November 18, 2024
Impact of time to antibiotics on clinical outcome in paediatric febrile neutropenia: a target trial emulation of 1685 episodesGabrielle M Haeusler, S Ghazaleh Dashti, Fiona James, et al.
The Lancet Regional Health. Western Pacific|May 3, 2021
Multi-site assessment of rapid, point-of-care antigen testing for the diagnosis of SARS-CoV-2 infection in a low-prevalence setting: A validation and implementation studyStephen Muhi, Nick Tayler, Tuyet Hoang, et al.
JAMA Internal Medicine|July 17, 2023
Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy: The PALACE Randomized Clinical TrialAna Maria Copaescu, Sara Vogrin, Fiona James, et al.
Open Forum Infectious Diseases|September 13, 2021
Defective Severe Acute Respiratory Syndrome Coronavirus 2 Immune Responses in an Immunocompromised Individual With Prolonged Viral ReplicationClaire L Gordon, Olivia C Smibert, Natasha E Holmes, et al.
BMJ Open|August 17, 2022
Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)Fiona James, Michelle S Y Goh, Effie Mouhtouris, et al.
Research Square|August 31, 2021
Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severityWuji Zhang, Brendon Chua, Kevin Selva, et al.
Nature Communications|November 24, 2025
High expression of interleukin-18 receptor alpha correlates with severe respiratory viral disease and defines T cells with reduced cytotoxic signaturesAira F Cabug, Jeremy Chase Crawford, Hayley A McQuilten, et al.
Immunity|May 5, 2021
CD8<sup>+</sup> T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuityThi H O Nguyen, Louise C Rowntree, Jan Petersen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2026
Direct Oral Challenge for Penicillin Allergy: A Hospital Implementation Evaluation Via the International Network of Antibiotic Allergy Nations (iNAAN) StudyElise A Mitri, Sara Vogrin, Camille Paynter, et al.
Pageof 7